Literature DB >> 18987871

Ameliorative effect of PN-277 on laser-induced retinal damage.

Shiri Shulman1, Mark Belokopytov, Galina Dubinsky, Michael Belkin, Mordechai Rosner.   

Abstract

BACKGROUND: The retinal damage induced by laser photocoagulation increases considerably by the secondary degeneration process whereby tissues adjacent to the primary lesion are destroyed. As the neuroprotective effect of immunization by PN-277 was previously demonstrated in models of retina, optic nerve, brain, and spinal cord lesions, it may be used also for reducing retinal damage induced by laser. The aim of this study was to evaluate the neuroprotective effect of immunization with PN-277 in reducing the spread of laser-induced retinal damage.
METHODS: Standard argon laser lesions were created in 36 DA pigmented rats. Seven days before exposure to laser, the rats were divided into a test group (n = 18) that was pre-immunized with intraperitoneal injection of PN-277 and control group (n = 18) treated with saline. Histological and morphometrical evaluations of the retinal lesions were preformed 3, 20, and 60 days after the injury.
RESULTS: Significant ameliorative effect was demonstrated in the retinas of the pre-immunized animals 60 days after exposure to laser. The diameter of the lesion was 356 microm as compared with 406 microm (P < 0.01), the cell density of the photoreceptor cell bodies measured in the whole lesion was 72.4% of normal as compared with 64.5% (P = 0.01), and at the center of the lesion it was 57.3% of normal as compared with 38.2% (P < 0.01) (treated and control groups, respectively).
CONCLUSIONS: Immunization with PN-277 has an ameliorative effect in neural tissue such as the retina. This type of immunization may be of clinical significance in reducing laser-induced retinal injuries in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987871     DOI: 10.1007/s00417-008-0975-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  23 in total

1.  Autoimmune T cells as potential neuroprotective therapy for spinal cord injury.

Authors:  E Hauben; U Nevo; E Yoles; G Moalem; E Agranov; F Mor; S Akselrod; M Neeman; I R Cohen; M Schwartz
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

2.  Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury.

Authors:  Ehud Hauben; Amalia Gothilf; Avi Cohen; Oleg Butovsky; Uri Nevo; Igor Smirnov; Eti Yoles; Solange Akselrod; Michal Schwartz
Journal:  J Neurosci       Date:  2003-09-24       Impact factor: 6.167

3.  Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

Authors:  J Fisher; H Levkovitch-Verbin; H Schori; E Yoles; O Butovsky; J F Kaye; A Ben-Nun; M Schwartz
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

4.  Nitric oxide synthase in the human glaucomatous optic nerve head.

Authors:  A H Neufeld; M R Hernandez; M Gonzalez
Journal:  Arch Ophthalmol       Date:  1997-04

Review 5.  Laser eye injuries.

Authors:  Y Barkana; M Belkin
Journal:  Surv Ophthalmol       Date:  2000 May-Jun       Impact factor: 6.048

6.  Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity.

Authors:  G Moalem; A Gdalyahu; Y Shani; U Otten; P Lazarovici; I R Cohen; M Schwartz
Journal:  J Autoimmun       Date:  2000-11       Impact factor: 7.094

Review 7.  Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases.

Authors:  Michal Schwartz; Jonathan Kipnis
Journal:  J Neurol Sci       Date:  2005-04-20       Impact factor: 3.181

8.  Functional deficits resulting from laser-induced damage in the rat retina.

Authors:  Gil Ben-Shlomo; Mark Belokopytov; Mordechai Rosner; Galina Dubinsky; Michael Belkin; Yoram Epstein; Ron Ofri
Journal:  Lasers Surg Med       Date:  2006-08       Impact factor: 4.025

9.  Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies.

Authors:  E Yoles; M Schwartz
Journal:  Exp Neurol       Date:  1998-09       Impact factor: 5.330

10.  Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

Authors:  M Kerschensteiner; E Gallmeier; L Behrens; V V Leal; T Misgeld; W E Klinkert; R Kolbeck; E Hoppe; R L Oropeza-Wekerle; I Bartke; C Stadelmann; H Lassmann; H Wekerle; R Hohlfeld
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

View more
  2 in total

1.  The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation.

Authors:  Somaia Mitne; Sergio Henrique Teixeira; Michal Schwartz; Michael Belkin; Michel Eid Farah; Nilva S Bueno de Moraes; Luciana da Cruz Nóia; Angela Tavares Paes; Cláudio Luiz Lottenberg; Augusto Paranhos Júnior
Journal:  Clin Ophthalmol       Date:  2011-07-15

2.  Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1.

Authors:  Bo Yu; Hui Shao; Chang Su; Yuanfeng Jiang; Xiteng Chen; Lingling Bai; Yan Zhang; Qiutang Li; Xiaomin Zhang; Xiaorong Li
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.